Table 3.
Age-standardized incidence rates (cases per 1 million) of gonadal and extragonadal germ cell tumors by primary site, sex and race; SEER-9, 1973–2007
| Topography (ICD-O) | Males
|
Females
|
||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| White | Black | White | Black | |||||||||
| N | ASR | SE | N | ASR | SE | N | ASR | SE | N | ASR | SE | |
|
|
||||||||||||
| Gonadal germ cell tumors | ||||||||||||
| Testis (C62.0–C62.9) | 19,517 | 56.3 | 0.41 | 442 | 10.0 | 0.49 | ||||||
| Ovary (C56) | 1,095 | 3.2 | 0.10 | 175 | 1.9 | 0.1 | ||||||
| Primary sites of extragonadal germ cell tumors | ||||||||||||
| Thymus (C37.9) | 18 | 0.1 | 0.01 | 0 | 2 | 0 | ||||||
| Mediastinum (C38.1–C38.3) | 406 | 1.2 | 0.06 | 25 | 0.5 | 0.11 | 38 | 0.1 | 0.02 | 3 | ||
| Retroperitoneum (C48.0) | 154 | 0.5 | 0.04 | 7 | 13 | 6 | ||||||
| Pelvis (C49.5, C76.3) | 39 | 0.1 | 0.02 | 4 | 60 | 0.2 | 0.02 | 18 | 0.3 | 0.17 | ||
| Uterus (C54–C55) | 46 | 0.1 | 0.02 | 23 | 0.3 | 0.09 | ||||||
| Female genital tract (C57) | 23 | 0.1 | 0.01 | 2 | ||||||||
| Placenta (C58) | 312 | 0.9 | 0.05 | 92 | 1.7 | 0.17 | ||||||
| Brain, NOS (C71.0–C71.9) | 83 | 0.2 | 0.03 | 8 | 41 | 0.1 | 0.02 | 11 | ||||
| Pineal gland (C75.3) | 175 | 0.5 | 0.04 | 23 | 0.4 | 0.09 | 10 | 0 | ||||
| Pituitary gland (C75.1) | 20 | 0.1 | 0.01 | 0 | 16 | 0.0 | 0.01 | 1 | ||||
| Malignant neoplasm of other and ill-defined sites (C76excl. C76.3) | 8 | 1 | 2 | 0 | ||||||||
| Other sites* | 60 | 0.2 | 0.02 | 9 | 52 | 0.2 | 0.02 | 19 | 0.4 | 0.09 | ||
| Unknown primary site (C80.9) | 162 | 0.5 | 0.04 | 9 | 27 | 0.1 | 0.02 | 7 | ||||
| All extragonadal germ cell tumors | 1,125 | 3.3 | 0.10 | 86 | 1.8 | 0.20 | 641 | 1.9 | 0.07 | 182 | 3.4 | 0.25 |
all other sites had less than 16 registered cases in each sex-race stratum of the registration period 1973–2007; ASR: age-standardized rate; SE: standard error of ASR